Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why uniQure Stock Is Crashing Today

TheMotleyFool 
0 0 21.06.23
Why uniQure Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/737059/dna-on-monitor-scientists.jpg
 

Shares of uniQure NV (NASDAQ: QURE) are plummeting today, down by 40% as of 11:09 a.m. ET. The steep decline came after the company announced interim results from a phase 1/2 clinical study evaluating experimental gene therapy AMT-130 in treating Huntington's disease, a rare neurogenerative disease.

uniQure president of research and development Ricardo Dolmetsch stated that the company was "very pleased" with the interim results. So why did the biotech stock plunge? There were some concerns with the data for AMT-130.

For example, the group of patients treated with the high dose of AMT-130 experienced a 51.5% increase in neurofilament light chain (NfL) protein levels in their cerebrospinal fluid. Higher levels of NfL are viewed as a sign of deteriorating neurodegenerative disease.

Continue reading


Source Fool.com

Ricardo plc Stock

€5.30
2.910%
There is an upward development for Ricardo plc compared to yesterday, with an increase of €0.15 (2.910%).

Show more
Like: 0
QURE
Share

Comments

Not a member yet? Sign up for free!